Offering will be conducted with Woodford Investment at $5.50 per share
By Devika Patel
Knoxville, Tenn., Oct. 21 – Northwest Biotherapeutics, Inc. said it plans a $30 million private placement of stock with Woodford Investment Management LLP.
The company will sell 5,454,545 common shares at $5.50 apiece. The price per share is a 17.52% premium to the Oct. 20 closing share price of $4.68.
Northwest is a development-stage biotechnology company based in Bethesda, Md.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Common shares
|
| Amount: | $30 million
|
| Shares: | 5,454,545
|
| Price: | $5.50
|
| Warrants: | No
|
| Investor: | Woodford Investment Management LLP
|
| Pricing date: | Oct. 21
|
| Settlement dates: | Oct. 22
|
| Stock symbol: | Nasdaq: NWBO
|
| Stock price: | $4.68 at close Oct. 20
|
| Market capitalization: | $397.1 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
